FTC Sues Hims & Hers Over Health Data Sharing

The Federal Trade Commission filed suit against telehealth platform Hims & Hers, alleging it shared users' sensitive health information with Meta and Snap without proper consent and trapped consumers in subscriptions. The lawsuit centers on violations of consumer privacy protections.

Hims & Hers Faces FTC Lawsuit & Board Probe | Telehealth.org

EXCLUSIVE: US FTC suing Hims & Hers for sending user health info to Meta, Snap - Reuters

HDC Deadline: HDB Investors Have Opportunity to Lead HDFC Bank Limited Securities Fraud Lawsuit

NEW YORK, Sept.

'They Are Thieves': FTC Complaints About Hims & Hers Detail Surprise Charges

FTC sues Hims & Hers over data sharing and billing practices

The Federal Trade Commission, along with the states of California and Utah, sued telehealth company Hims & Hers over alleged unauthorized sharing of health data with Meta and Snap, deceptive billing practices, and difficulties canceling subscriptions. Hims & Hers stock fell 10% following the lawsuit announcement.

HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit

NEW YORK, Sept.

FTC sues Hims & Hers for sharing patients' medical data with Meta, Snap

The FTC filed suit against Hims & Hers, a telehealth platform prescribing sexual wellness and mental health treatments, for using website trackers to share customer medical data with advertisers Meta and Snapchat without adequate consent (July 2026).

Stocks making the biggest moves midday: Expedia, Nvidia, Strategy, Hims & Hers and more

FTC and States Act Against Hims & Hers for Deceptive and Unlawful Privacy Practices

Nvidia leads new Open Secure AI Alliance without major labs

Nvidia, Microsoft, SpaceX, IBM and 30+ technology partners launched the Open Secure AI Alliance on July 27 to develop open-source AI security tools and models. The alliance notably excludes OpenAI, Google, and Anthropic, appearing to respond to recent AI security breaches.

Hims & Hers accused of sharing health secrets and hiding the cancel button

The products are popular with a group of unlikely allies, including the “looksmaxxing” and fitness communities, longevity experts, dermatologists and medical spas, and companies that operate compoundi

Novo sues Lilly amid escalating weight-loss rivalry

Telehealth companies keep exposing their customers’ medical data. What should they do? - AP News

Telehealth companies keep exposing their customers’ medical data. What should they do?

FDA Committee Votes for Peptide Availability Despite Opposition

An FDA committee voted on July 24, 2026 to recommend making certain peptides available through compounding pharmacies despite FDA staff opposition. Critics noted that some committee members have financial ties to peptide producers, raising conflict-of-interest concerns.